Head-to-Head Comparison of UHPLC-MS/MS and Alinity C for Plasma Analysis of Risperidone and Paliperidone
<b>Background and objectives:</b> Risperidone, a second-generation antipsychotic widely used in the treatment of schizophrenia, requires therapeutic drug monitoring due to its high interindividual variability. UHPLC-MS/MS is considered the gold standard for pharmacokinetic studies owing...
Saved in:
| Main Authors: | Francisco José Toja-Camba, Gonzalo Hermelo-Vidal, Carolina Feitosa-Medeiros, María Vidal-Millares, María José Durán-Maseda, Anxo Fernández-Ferreiro, Cristina Mondelo-García |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-10-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/17/11/1446 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Population Pharmacokinetics of Risperidone and Paliperidone in Schizophrenia: A Systematic Review
by: Ana Carrascosa-Arteaga, et al.
Published: (2025-05-01) -
A case report of exacerbation of extrapyramidal symptoms following the switch from risperidone to paliperidone during valproate therapy
by: Emi Hata, et al.
Published: (2025-01-01) -
Chemical and Toxicological Diagnosis of Acute Poisoning with Clozapine, Olanzapine, Quetiapine and Risperidone
by: M. V. Belova, et al.
Published: (2020-10-01) -
Validation of a method for the quantitative determination of narcotic and psychotropic substances in urine by UHPLC–MS/MS
by: N. B. Savelieva, et al.
Published: (2022-07-01) -
Development and Validation of a New LC-MS/MS Method for Simultaneous Quantification of Ivacaftor, Tezacaftor and Elexacaftor Plasma Levels in Pediatric Cystic Fibrosis Patients
by: Alessandro Mancini, et al.
Published: (2025-07-01)